AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2021

Jul 2, 2021

30870_dirs_2021-07-02_e3c47fe4-0eee-4516-8c70-dbff0d700175.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-01-05

Reporting Person: Wysenski Nancy (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	255	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$15.99	2030-11-20	Common Stock (35000)		Direct

Footnotes

F1: This option shall vest and become exercisable as to 35,000 shares divided into equal monthly installments with the first vesting installment on December 20, 2020 and the final vesting installment on November 20, 2023.